2.29 CNY
800.91 M CNY
3.10 B CNY
124.61 M
About TIBET RHODIOLA PHARMACEUTICAL HOLDING CO.
Sector
CEO
Yuan Dong Guo
Headquarters
Chengdu
Website
Founded
1999
ISIN
CNE000000ZW7
FIGI
BBG000BZHVY5
Tibet Rhodiola Pharmaceutical Holding Co. engages in the manufacture and wholesale of pharmaceutical products. Its main products include Chinese patent medicine, biological products, and chemical medicine. The company was founded on July 14, 1999 and is headquartered in Lhasa, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 600211 is 40.14 CNY — it has decreased by −0.15% in the past 24 hours. Watch TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. stocks are traded under the ticker 600211.
600211 stock has risen by 7.44% compared to the previous week, the month change is a −9.06% fall, over the last year TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. has showed a −1.64% decrease.
600211 reached its all-time high on Aug 4, 2020 with the price of 140.05 CNY, and its all-time low was 1.53 CNY and was reached on Jul 20, 2005. View more price dynamics on 600211 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
600211 stock is 3.79% volatile and has beta coefficient of 1.35. Track TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. stock price on the chart and check out the list of the most volatile stocks — is TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. there?
Today TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. has the market capitalization of 12.94 B, it has decreased by −5.02% over the last week.
Yes, you can track TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. financials in yearly and quarterly reports right on TradingView.
600211 net income for the last quarter is 168.73 M CNY, while the quarter before that showed 310.22 M CNY of net income which accounts for −45.61% change. Track more TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. financial stats to get the full picture.
TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. dividend yield was 3.97% in 2023, and payout ratio reached 60.03%. The year before the numbers were 2.08% and 50.01% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 10, 2024, the company has 601.00 employees. See our rating of the largest employees — is TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. on this list?
Like other stocks, 600211 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. stock shows the strong buy signal. See more of TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.